The metabolic basis of familial hypercholesterolaemia
- 1 April 1983
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 61 (8) , 383-401
- https://doi.org/10.1007/bf01488153
Abstract
Familial hypercholesterolaemia (FH) is a dominantly inherited error of metabolism characterised by a raised plasma low-density lipoprotein (LDL) concentration, xanthomas of skin and tendons, and a tendency to premature heart disease due to atherosclerosis of the coronary arteries. The clinical and biochemical abnormalities are more marked in homozygotes than in heterozygotes. Other biochemical changes include an increased concentration of very-low-density lipoprotein (VLDL) remnants and of a minor subfraction of high-density lipoproteins. Measurement of plasma lipoprotein turnover shows reduced fractional rates of catabolism of LDL and VLDL remnants, and increased production of LDL. Similar abnormalities are found in Watanabe rabbits, an inbred strain carrying a mutation similar to that responsible for FH. Cultured cells from human and animal tissues express surface receptors with high binding affinity for LDL. Binding of LDL to LDL receptors is followed by cndocytosis and lysosomal digestion of the lipoprotein. Cultured cells from FH heterozygotes express only half the normal number of LDL receptors; those from homozygotes have little or no receptor activity and are therefore unable to degrade significant amounts of LDL by the LDL-receptor pathway. The LDL receptor has been isolated from cell membranes; it has a molecular weight of about 160 kd. Several different mutant forms of the receptor have been identified in the cells of FH homozygotes. The LDL-receptor pathway for the catabolism of LDL accounts for at least 1/3 of the total LDL catabolised by normal human subjects in vivo and almost none of that catabolised by FH homozygotes. Deficiency of LDL receptors accounts for the increased plasma concentrations of LDL and VLDL remnants in FH. The increased plasma concentration in these lipoproteins is the cause of deposition of lipid in xanthomas and arterial wall, but the mechanism by which lipoprotein enters the cells in which lipid accumulates is not yet understood.Keywords
This publication has 101 references indexed in Scilit:
- Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.Journal of Clinical Investigation, 1981
- Individual Variation in the Effects of Dietary Cholesterol on Plasma Lipoproteins and Cellular Cholesterol Homeostasis in ManJournal of Clinical Investigation, 1981
- Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cellSBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- WHHL‐Rabbit: a low density lipoprotein receptor‐deficient animal model for familial hypercholesterolemiaFEBS Letters, 1980
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Quantitative studies of ver low densit lipoprotein: conversion to low densit lipoprotein in normal controls and primar hperlipidaemic states and the role of direct secretion of low densit lipoprotein in heterozgous familial hpercholesterolaemiaEuropean Journal of Clinical Investigation, 1980
- Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
- Catabolism of Very Low Density Lipoprotein B Apoprotein in ManJournal of Clinical Investigation, 1978
- Concentration of lipoproteins containing apolipoprotein B in human peripheral lymphBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteinsFEBS Letters, 1975